Tate & Lyle’s century-long presence on the London stock market is set to come to an end after the British ingredients manufacturer agreed to a £2.7 billion takeover by its American competitor, Ingredion.
The deal marks another high-profile acquisition of a UK-listed business by an overseas buyer, adding to growing concerns about the shrinking number of major firms listed in Britain.
Historic British Firm Agrees to US Takeover
The agreement will see Tate & Lyle leave the London Stock Exchange after more than a century of corporate history.
The company traces its roots back to 1921, when two family-owned sugar businesses in Liverpool combined to form what would become one of Britain’s best-known food brands.
Under the terms of the transaction, shareholders will receive 595 pence per share in cash, alongside dividends worth 20 pence per share.
The total value of 615 pence per share represents a substantial premium for investors and reflects the strategic value Ingredion sees in the business.
Shareholders Rewarded With Significant Premium
The takeover proposal offers investors a 64 percent premium compared with Tate & Lyle’s share price before Ingredion publicly disclosed its interest in the company.
Speculation surrounding a potential acquisition had already driven investor enthusiasm.
Two weeks earlier, the companies confirmed they were discussing a possible deal, triggering a surge of more than 45 percent in Tate & Lyle’s share price.
Following confirmation of the agreement on Monday, shares in the FTSE 250 company climbed a further 12.3 percent to 552 pence.
Business Faced Challenging Trading Conditions
The takeover comes after a difficult period for Tate & Lyle. The company issued a warning about full-year profits last October and later reported a 10 percent decline in first-half earnings during November.
Like many businesses in the food sector, the firm has faced pressure from softer consumer demand, increasing operating costs, and changing dietary trends.
Industry observers have also pointed to the growing popularity of weight-loss medications as a factor influencing demand patterns across parts of the food market.
Tate & Lyle has undergone significant transformation over the past decade.
In 2010, it sold the European operations of its traditional sugar business, including the famous Lyle’s Golden Syrup brand, to American Sugar Refining as part of a broader shift toward specialty food ingredients.
Ingredion Sees Growth Opportunities
Commenting on the acquisition, Jim Zallie said the combined company would be in a stronger position to help customers develop food products that are healthier, affordable, and appealing to consumers.
According to Zallie, bringing the two businesses together will enhance their ability to respond to changing consumer preferences while expanding innovation capabilities across the food and beverage sector.
Fresh Blow to London’s Stock Market
The takeover is the latest example of overseas buyers targeting British-listed companies, raising further questions about the attractiveness and valuation of UK equities.
Only last week, Evoke agreed to a £243 million acquisition by Greek gaming group Intralot.
The trend has extended to some of Britain’s largest listed businesses.
Recently, testing and inspection company Intertek backed a £9.4 billion offer from Swedish private-equity group EQT.
That followed the £9.9 billion takeover of Schroders by US-based Nuveen and an £8.1 billion deal that saw insurer Beazley agree to be acquired by Zurich Insurance Group.
With another established British name set to pass into foreign ownership, the sale of Tate & Lyle is likely to intensify debate over whether UK-listed companies are being undervalued and increasingly viewed as attractive takeover targets by international buyers.
